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Abstract
The aim of this study was to investigate the differences in the in vivo degradation behaviour of magnesium implants with
various grain sizes and damaged surfaces. For this purpose, three different LAE442 magnesium implants were produced:
cast, single and double extruded implants, in order to obtain different grain sizes. Furthermore, defects were positioned
on the surfaces of some of the single extruded implants. The initial stability was determined. Four pins of each implant
material were implanted into rabbits’ tibiae and regularly clinically, radiologically and m-computed tomographically inves-
tigated over a period of 27 weeks. Following explantation, investigations were carried out using stereo and scanning
electron microscopy including energy-dispersive X-ray analyses. Weight and strength changes were measured. The dou-
ble extruded implants possessing the finest grains exhibited the highest initial stability (179.18 N). These implants
demonstrated the lowest in vivo corrosion rates (0.0134 mm/year) and the least radiologically visible changes. The high-
est corrosion rate was computed for the implants possessing damaged surfaces. Radiologically discernible bone changes
occurred at almost the same time as implant changes for all groups. Based on these results, the aim should be to pro-
duce fine-grained magnesium-based alloys for resorbable implants and to avoid any surface damage.
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Introduction
Owing to its favourable properties such as good bio-
compatibility and mechanical stability, degradable
implant materials based on magnesium are the focus of
current biomedical materials research.1–8 Besides good
biocompatibility, degradable implants must exhibit suf-
ficient strength in order to be employed in load-carrying
bone. Current degradable implant materials, such as
ceramics and polymers, lack this strength.9,10 In con-
trast, magnesium alloys have similar mechanical prop-
erties to bone.2 By means of additionally alloying with
other elements, such as calcium, lithium, aluminium or
rare earths, the degradation properties and the strength
of magnesium alloys can be influenced and thus lower
the degradation rate and thereby reduce gas develop-
ment.3,5,11–13 Besides the composition, surface process-
ing and/or impairment of the surface, which could
happen, for example, during the insertion of intramed-
ullar osteosynthetic materials, also influence the magne-
sium implant’s degradation.14,15 Roughened surfaces
ofMgCa cylinders lead to increased corrosion in vivo,14
while surface damage of AZ91 specimens showed a
higher in vitro corrosion in simulated body fluid
(SBF).15 The grain size as an additional parameter can
also affect the degradation behaviour. The AZ31 mag-
nesium alloy possessing finer grains demonstrated a
better corrosion resistance in in vitro tests in SBF as the
same alloy with coarser grains.16 Consequently, grain
refinement could improve the corrosion behaviour and
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possibly help to systematically control the corrosion.
Grain refinement can, among others, be carried out by
means of extrusion,17,18 which leads to recrystallization
and the formation of new and fine grains via mechani-
cal and thermal processes.18,19
The promising magnesium-based alloy LAE442
(containing 4 wt% lithium, 4 wt% aluminium and
2wt% rare earths) demonstrated slow degradation with
a subsequent low impact on the surrounding tissue that
would allow for an adequate bone healing, as well as
good biocompatibility.1,20 The influence of various
grain sizes on this alloy’s degradation and biocompat-
ibility has not been previously tested. Therefore, it was
the objective of this study to investigate the degrada-
tion behaviour of LAE442 with various grain sizes over
a period of 6 months in vivo. Additionally, the influ-




All implants used in this study were made of the
magnesium-based alloy LAE442 (4 wt% lithium,
4 wt% aluminium and 2 wt% rare earths.21 A total of 42
implants were manufactured using the casting process in
a protective gas atmosphere of atal. Further processing
prior to turning the material to the final implant’s size
(25mm in length and 2.5mm in diameter) varied, such
that four different implant types were generated:
type 1: no extrusion;
type 2: extrusion from 120 to 30mm at 350 C;
type 3: first extrusion from 120 to 30mm at 350 C, sec-
ond extrusion from 30 to 10mm at 350 C;
type 4: extrusion from 120 to 9mm at 350C; after
obtaining the implant’s final size, four longitudinal
notches at the proximal end and three transverse
notches in the middle of the implant were produced
using a 22-gauge needle (Braun, Germany).
All implants were weighed, washed with acetone and
distilled water, packed in special sterilization bags and
sterilized using gamma radiation (27.9 kGy; BBF
Sterilisationsservice, Germany). Using a universal test
machine (Zwick, Germany), the mechanical properties
of four implants of type 1, type 2 and type 3 were deter-
mined by four-point bending tests as previously
described.1,3 Therefore, the implants were placed cen-
trally on the abutments with a distance of 15mm
between supports. A displacement transducer measured
the distance during the test cycle. Before the test, a pre-
load of 2.5 N was applied. The subsequent downward
movement of the forming punch was at a constant
speed of 1mm/min. Termination criteria were a sudden
drop of force of 10% or a bending of 5mm. The maxi-
mum force (Fmax (N)) and the bending displacement
at fracture (å-Fmax (mm)) were recorded.
In metallographic examinations, the grain size of
type 1, type 2 and type 3 implants was determined three
times according to DIN EN ISO 643, generally at a
magnification of 100:1. The number of grains (Kw)
within a gauge circle of 5000mm2 (surface Acircle) corre-
sponding to a diameter of 79.8mm was counted, while
the grains cut by the circle’s edge (Kc) were added to
the total number as only half grains. The computation
of the mean grain size (Kmid) was performed subject to









The surface of every implant was examined micro-
scopically (Axio CamMRC; Carl Zeiss AG, Germany)
using 5- to 40-fold magnifications. The implants’ sur-
faces were evaluated descriptively.
Animal model
The animal tests were approved by the local govern-
ment of Hannover (reference number 33.9-42502-04-07/
1363). Four cylinders of each implant type were inserted
longitudinally in the medullary cavity of adult New
Zealand white rabbits (Charles River, Deutschland).
Each animal received two implants of the same type.
Surgery was carried out as previously described.1 The
implantation period was 6 months. Clinical examina-
tions during the post-operative period focussed on red-
ness, soft/hard swellings, lameness, development of gas,
purulence or suture dehiscence. Both tibiae were radi-
ologically examined weekly in the mediolateral and
anteroposterior beam path using 48 kV and 6.3 mAs
(Practix 160; Philips, Germany). The implants were
assessed using semi-quantitative scores described by
Huehnerschulte et al.3 Three different parts were
assessed: the implant itself (structural changes), the
bone changes of the diaphysis, the corticalis and at the
implantation site and gas formation. Score values were
given from 0 (no change) to 3 (severe change).3 All
parameters were summed to a cumulative score and
depicted graphically.
According to Huehnerschulte et al.,3 every second
week, up to week 12, and then every fourth week as
well as on the day of euthanization, m-computed tomo-
graphies (mCTs) were performed (XtremeCT; Scanco
Medical, Switzerland) under general anaesthesia. The
implants were manually contoured and subsequently
measured by means of the mCT software evaluation
program V6.1 (XtremeCT; Scanco Medical). The
threshold was adapted for each group (type 1, type 2:
138; type 3: 236), and the following parameters were
evaluated: volume, density and true three-dimensional
(3D) thickness as well as the standard deviation (SD)
of the true 3D thickness. The latter equates to the var-
iance of the maximum diameters within an implant3
and will subsequently be named ‘variance’. It displays
the homogeneity of the overall degradation of an
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implant.3,22 The implant’s corrosion rate was calculated
using the in vivo mCT data according to the following
formula: CR=DV/(A 3 t).23 Here, CR (mm/year) is
the corrosion rate, DV (mm3) is the volume loss, A
(mm2) is the area that was exposed to the corrosion
and t (days) is the implantation period.
Evaluation of the implants ex vivo
After 6 months, the animals were anaesthetized using s-
ketamine hydrochloride (20mg/kg; CP-Pharma,
Germany) and xylazinhydrochloride (5mg/kg;
Serumwerk Bernburg AG, Germany) and painlessly
euthanized by an intracardial injection of pentobarbital
(230mg/kg; Narkodorm CP-Pharma, Germany). The
tibiae were opened longitudinally using a Dremel
rotary cutter, and the implants were carefully removed
and examined microscopically.
For further evaluation of the implant’s surface, one
implant of each group was examined by means of scan-
ning electron microscopy (SEM) (LEO VP 1455; Zeiss,
Germany). At selected locations, an element analysis
was performed using energy-dispersive X-ray (EDX)
spectroscopy (X-flash Detector 5010; Bruker, Germany).
SEM images with Rutherford Backscattering Spectros-
copy (RBS) and Variable Pressure Secondary Electrons
(VPSE) were taken (resolution: 5 nm). The evaluation
was performed descriptively.
To evaluate the volume loss of the implants, the
organic material was washed off with hydrofluoric acid
(40%).3,24 Following this, the implants were once more
microscopically and scanning electron microscopically
examined and weighed (AB204-S/Fact; Metler Toledo,
Germany). The average weight loss of each group is
expressed as the difference in percent of the remaining
implant, after hydrofluoric acid treatment, to the initial
weight before implantation. Subsequently, the mechan-
ical properties were determined analogous to the
mechanical testing in the initial condition.
Statistics
Statistical analysis was performed with Microsoft
Office Excel Version 2003 and SPSS Version 17.0.
After testing for normal distribution, statistical differ-
ences for weight changes, volume calculation and true
3D thickness, including variances, were determined by
means of t-tests for paired samples. Data for mechani-
cal properties were analysed using t-test for indepen-
dent samples. The evaluation of density changes
within a group was performed with tests according to
Wilcoxon. Comparisons between the groups were sta-
tistically investigated by means of a univariate analy-
sis of variance (ANOVA) with subsequent post hoc
tests (Tukey, Games-Howell). Values of p 4 0.05 and
p 4 0.01 were interpreted as significant and highly
significant, respectively.
Results
Examination of the initial implants
Three-point bending. Type 1 implants with 126.01 N (SD
12.87) exhibited a significantly lower maximum force
(Fmax) than type 2 (168.11 N (SD 4.79)) and type 3
(179.18 N (SD 9.83)) implants. Hence, on average, type
3 implants possessed a higher Fmax than type 2
implants, but no significance could be evaluated.
The average bending displacement at fracture
(å-Fmax (mm)) was 0.5mm (SD 0.036) for type 3
implants and was significantly lower (p=0.016 to
p \ 0.001) than those for type 2 (1.85mm (SD 0.43))
and type 1 (1.31mm (SD 0.42)) implants. No significance
could be calculated between type 1 and type 2 implants.
Metallographic examination. The average grain size
differed between the groups with a high significance
(p \ 0.01). Type 1 implants possessed the largest aver-
age grain size (36.85mm (SD 2.86)) (Figure 1(a)) in
comparison to type 2 (25.32mm (SD 2.67)) (Figure 1(b))
and type 3 implants (11.27mm (SD 0.6)) (Figure 1(c)).
Examination of the explanted pins Microscopic examination. Prior
to implantation, a distinct difference between the implant
types could be seen. Type 1 implants exhibited the broadest
transverse grooves (dependent on manufacturing) as well as
more unevenness around and on these grooves (Figure
2(a)). Type 3 implants possessed the narrowest transverse
grooves and the most homogeneous structure (Figure 2(c)).
The notches on the surface of type 4 implants could be
clearly identified (Figure 2(d)).
Animal model
Clinical examination. All animals showed minor-to-
moderate redness and swelling on both legs, which dis-
appeared no later than the 27th day after surgery.
Minor hard but painless swellings appeared around the
implantation site, on average, on the fifth day.
Moderate hard but painless swellings could be observed
between the 9th and the 26th day and were still present
in six animals on the day of euthanasia. One animal,
with type 1 implants, showed lameness, which altered
from minor to severe, from day 31 to day 68.
Depending on its severity, the lameness was treated
with meloxicam (0.15mg/kg, Metacam; Boehringer
Ingelheim, Ingelheim, Germany) and buprenorphine
hydrochloride (0.05mg/kg; Bayer AG, Leverkusen,
Germany). The development of gas in the form of subcu-
taneous emphysema could not be observed in any of the
animals.
Radiologic examination. The earliest radiological changes
in the form of growths at the diaphysis could be seen in
week 4 (type 2 implants). Structural changes of the
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implants, appearing as brightening, were first seen
(week 8) most distinctly in implants of type 1. The
structure of type 3 implants remained constant for the
longest period of time (until week 17). On average,
minor, diffuse intramedullary gas development could
be seen intermittently in all groups from the eighth
week up until the end of the observation period. Minor,
inhomogeneous structural changes of the corticalis as
well as growth at the implantation site played a minor
role in the total score, which increased with small fluctua-
tions in all groups over the time period (Figure 3). On
average, implants of type 3 showed the lowest total score
values, as well as the slightest bone changes, over the
entire observation period (Figure 3). Looking at the
implant changes and the bone changes separately, it
could be seen that they occurred at similar points in time.
In vivo mCT. The evaluation of the in vivo mCT showed
the lowest initial density for implants of type 4, whereas
highest density for implants of type 3 (Table 1). Over
time, a minor loss of density but with no significance
could be determined. As for the volume, a significant
loss could be calculated for every implant type. The
volume loss was most distinct for type 4 implants in
contrast to type 3 implants, which had the lowest
volume loss (Table 1). Over time, the diameter (true 3D
thickness) decreased, mainly homogeneously, in all
implant types. Here again, the type 4 implants showed
the highest and type 3 the lowest loss. The variance of
the diameter increased predominantly continuously in
all implant types over time. Throughout the examina-
tion, type 3 implants had the lowest variance values
(Table 1).
The calculated corrosion rates, based on the mCT
data (Table 1), showed a decrease over time. The high-
est corrosion rate after 2 weeks was determined for
implants with defects (type 4; 0.121mm/year). On aver-
age, type 3 implants exhibited the lowest corrosion rate,
which was 0.0134mm/year, at the end of the observa-
tion period. The corrosion rate of type 1 and type 2
implants was 0.035 and 0.025mm/year, respectively, at
the end of the observation period, whereas the implants
with defects again had the highest corrosion rate with
0.04mm/year.
Examination of the explanted pins
Microscopic examination. Directly after explantation, irre-
gular, uneven brown and white deposits as well as
cracks could be microscopically observed on the
Figure 1. Metallographic images with different grain sizes: (a) type 1, (b) type 2 and (c) type 3.
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implants. Moreover, type 3 implants showed fine trans-
verse grooves. The defects, appearing as longitudinal
notches, of the type 4 implants could still be seen on
three implants. The transverse notches could no longer
be seen on any of the implants.
After treating with hydrofluoric acid, an uneven sur-
face (type 1 and type 4), rounded ends (type 1 and type
2), longitudinal grooves (type 2, type 3 and type 4) as
well as pitting corrosion (in every implant type) could
be detected. One half of one type 3 implant showed an
inhomogeneous corrosion and a tapered end. The other
half of the same implant showed none of these changes.
In addition to this, this morphology could not be seen
prior to the hydrofluoric acid treatment. All other
implants exhibited none of these distinct differences.
SEM examination. Prior to treating with hydrofluoric
acid, all implants examined in the SEM had an uneven
and clump-like surface. The implants’ cylindrical form
was almost retained. It was possible to detect regions
containing rare earths as well as calcium- and
phosphate-rich deposits on the implants’ surface by
means of EDX analyses.
After treating with hydrofluoric acid, the type 1
implant showed an uneven surface, pitting corrosion,
oblique transverse grooves as well as distinct differ-
ences between the implants’ ends (Figure 4(a)). The
implants of the other types showed distinct longitudinal
lines, clump-like structures and also pitting corrosion
(Figure 4(b)). The proximal end of the type 3 implant
had longitudinal grooves and deposits, and the distal
end exhibited clump-like structures (Figure 4(c)). The
Figure 2. Microscopic images of the implants’ surfaces prior to implantation: (a) type 1 (320 magnification), (b) type 2 (320
magnification), (c) type 3 (320 magnification) and (d) type 4: artificial defects (longitudinal notches) at the end of the implants
(35 magnification).
Figure 3. Total radiological scores for the different groups
over time; a low total score represents only little changes of the
implant and the bone.
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proximal end of the type 4 implant had a distinctly
tapered form.
Weight determination. A significant (p=0.003 to
p\ 0.001) weight loss could be detected in all implants
after explantation (Figure 5). Type 1 implants had an
average loss of 33.23% and thereby the highest weight
loss. Implants of type 2, type 3 and type 4 showed
mean weight losses of 28.20%, 28.1% and 22.85%,
respectively.
Three-point bending test. The maximum force after
explantation and treating with hydrofluoric acid was
significantly (p=0.001 to p\ 0.001) lower than the
initial state for all implants (Figure 6). Type 1 (77.31 N
(SD 18.93)) implants had significantly lower values
after explantation than type 2 (99.38N (SD 6.85),
p=0.031) and type 3 (105.31N (SD 9.39), p=0.014)
implants. No significance could be determined between
types 2 and 3 implants, but, on average, type 3 implants
had higher values than type 2 implants (Figure 6).
Table 1. m-computed tomographic evaluation of density, volume, true 3D thickness and its variance.
Parameter Implant Value at implantation Value at explantation Difference in %
Density (mgHA/cm3) Type 1 1202.46 6 33.83a 1157.33 6 38.81A 23.75
Type 2 1311.0 6 135.65bc 1260.07 6 126.72BC 23.89
Type 3 2289.39 6 51.46abd 2254.14 6 65.72ABD 21.54
Type 4 1123.08 6 12.05cd 1104.1 6 16.48CD 21.69
Volume (mm2) Type 1 128.26 6 5.64* 124.54 6 3.76* 22.91
Type 2 129.85 6 3.28* 127.24 6 3.69* 22.01
Type 3 133.30 6 3.78* 131.89 6 4.3* 21.07
Type 4 130.95 6 0.8* 126.71 6 1.7* 23.24
True 3D thickness (mm) Type 1 2.3434 6 0.08a 2.2828 6 0.02A 22.59
Type 2 2.3822 6 0.01* 2.3143 6 0.03*B 22.85
Type 3 2.4730 6 0.05*a 2.4315 6 0.06*ABC 21.68
Type 4 2.4116 6 0.02 2.3100 6 0.08C 24.23
Variance of true 3D thickness Type 1 0.1482 6 0.06* 0.2830 6 0.08* + 91
Type 2 0.2047 6 0.05 0.2500 6 0.03 + 22
Type 3 0.1291 6 0.06 0.2009 6 0.09 + 56
Type 4 0.1713 6 0.02 0.2790 6 0.09 + 63
Small letters: significance between the groups at implantation; capital letters: significance between the groups at explantation; plain text: significant
(p4 0.05); bold: highly significant (p4 0.01); 3D: three-dimensional.
*Significance between value at implantation and explantation.
Figure 5. Weight determination of the different implant types, before and after trial; significances (p4 0.05) are marked with
asterisk.
Figure 6. Fmax: initial state and at the end of the observation
period; significances (p4 0.05) are marked with asterisk.
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The deflection at rupture after the observation
period had increased for all implant types. However, a
significant change (1.72mm (SD 0.41), p=0.01) in
comparison to the initial value (0.5mm (SD 0.42))
could only be detected for type 3 implants. No signifi-
cance was detected between the different implant types
at the end of the observation period.
Discussion
The objective of this study was to investigate the influ-
ence of various grain sizes and that of surface damage
on the in vivo degradation behaviour of the magnesium
alloy LAE442. Within this scope, the grain sizes,
mechanical properties and changes in volume, density
and weight were measured, and radiological investiga-
tions were performed. The implants’ morphology was
established by means of SEM and microscopy images.
In comparing the grain sizes in this study, the coarse-
grained implants showed the most severe loss of weight
and volume as well as the highest corrosion rate and
therefore a rapid degradation, while the fine-grained
(type 3) implants exhibited the lowest corrosion rates
and the least loss of volume and weight. In in vitro
studies, Alvarez-Lopez et al.16 also found a better cor-
rosion resistance for the fine-grained AZ31 alloys. The
authors attributed this to the strong negative corrosion
potential and to the associated rapid electrochemical
reaction with the formation of a protective layer from
the corrosion products.16 The results of the present
study show that such an effect of the grain size on the
corrosion can also be confirmed in vivo.
It initially appears to be contradictory that a fine-
grained implant was more strongly degraded on one
side. Following explantation and treating with hydro-
fluoric acid, a partly very inhomogeneous, uneven sur-
face was visible. In contrast, prior to treating with
hydrofluoric acid, there was no evidence for a non-
uniform degradation of this type 3 implant. Quite the
opposite; the in vivo variance of the maximum diameter
was always lower than those of the other groups. The
volume, density and weight loss were also lower in com-
parison with the coarse-grained implants. Moreover,
fine-grained implants exhibited the lowest corrosion
rates. Subsequent to treating with hydrofluoric acid,
the other implants of types 1, 2, 3 and 4 exhibited a
more clearly visible corrosion than prior to the hydro-
fluoric acid treatment as well. As previously mentioned,
it is described in the literature that grain refining leads
to an elevated in vitro corrosion resistance and, more-
over, to a more uniform degradation.8,16,25 A possible
cause for the inhomogeneous degradation of one type 3
implant, which is visible following hydrofluoric acid
treatment, can be sought in the formation of phases in
a magnesium alloy. Magnesium–aluminium alloys
mainly consist of an a-matrix, â-phases and other inter-
metallic particles on which corrosion pits frequently
develop.5 For small grain sizes, the â-phase forms an
almost continuous network and can lead to certain cor-
rosion protection.26 Moreover, the corrosion occurs,
above all, in and from a-grain to a-grain and fre-
quently stops at the grain boundaries before they reach
the b-phase.25 Consequently, a brittle, honeycomb-
shaped structure develops in vitro by means of the
remaining â-phase.25 Prior to treating with hydrofluoric
acid, the corrosion products, bonded with organic
material, could be held in situ by means of the â-phase
and were only then dissolved away by the hydrofluoric
acid treatment. This would explain why no deep corro-
sion could be discerned on the implant prior to treating
with hydrofluoric acid.
The computed in vivo corrosion rate demonstrated
the highest values for implants possessing defects (type
4). In the course of time, the corrosion rate of all the
investigated implants decreased. This was also
described by other authors for magnesium alloys and is
attributed by Witte et al. (for the alloys LAE442 and
AZ91D) to the formation of a stable corrosion layer
subsequent to the initial corrosion directly following
surgery.20,21,23 Furthermore, the formation of a calcium
phosphate film on the magnesium implants’ surface
impedes the in vitro formation of local corrosion.15
Witte et al.4 assume that this effect could also occur in
vivo. In this study, it was possible to verify the presence
of calcium and phosphorus on all implants using the
SEM/EDX analyses. Other in vivo studies also sub-
stantiate the verification of calcium and phosphorus on
the surfaces of implants based on magnesium in guinea
pigs (6 and 8 weeks)4 and rats (6 months)27 as well as
in vitro in SBF.28,29 However, the propagation of pre-
existing notches and cracks is more rapid in vitro than
the formation of the protective calcium phosphate
film.15 This effect could also occur in vivo and explain
the highest average corrosion rates of defective
implants (type 4) found in this study. The significant
tapering and thereby marked degradation of the proxi-
mal end of the type 4 implants can also be explained by
means of this.
The corrosion rate calculated on the basis of mCT
data regarding the volume loss differed obviously from
the corrosion measured by the weight loss method.
Although the weight loss method is commonly used to
reliably quantify the implant degradation of either in
vitro or in vivo studies,25,30 it has to be considered that
the removal of the adherent corrosion products prior
to weighing could possibly damage the implant or does
not succeed completely. With the used in vivo mCT, no
previous treatment is necessary to evaluate the
implants, but the resolution is not sufficient to distin-
guish between the implant itself and the corrosion
layer. Huehnerschulte et al.3 reported on similar results,
which could explain the differences between the results
of both evaluation methods. In addition, the SEM
analysis supports this, which showed distinct differ-
ences of the implants surfaces prior to and after hydro-
fluoric acid treatment. Other studies calculated the
corrosion rate of magnesium alloys after in vivo
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implantation and gained different results depending on
the method used.3,23,31 In vivo mCT data–based corro-
sion rates were generally slower3 than corrosion rates
calculated via weight loss method31 or volume loss/pit-
ting factor.23 All studies including the present examina-
tions show in common that the corrosion rate changes
over the course of time, and therefore, the definite end
point of degradation has to be determined by animal
studies that last long enough to show the total implant
degradation.
Radiologically identifiable changes in the implant
and the bone found in this study were also described by
other authors for in vivo intramedullar implants that
are based on magnesium.3,4,6,7 Diaphyseal changes
occurred in the current study almost synchronously
with the implant’s changes. This could be explained by
means of the gas that arises during the corrosion of the
magnesium2,4,32,33 and that is diffused and resorbed at
various rates depending on the surrounding tissue.4,8 In
this study, it was possible to radiologically see small
amounts of gas in the bone’s medullary cavity from, on
average, the eighth week. Huehnerschulte et al.3 also
found gas by means of mCT in bone in in vivo tests
with magnesium-based alloys in rabbits’ tibiae but not
in the surrounding tissue. Increased pressure could be
exerted on the bone due to the gas accumulated in the
medullary cavity. The bone reacts to mechanical load-
ing by increasing the bone tissue.34,35 This could explain
the chronological correlation of the additional diaphy-
seal formation with the implants’ degradation. Another
possible explanation could be the elevated activity of
osteoblasts, which was assumed by Witte et al.,4,36 due
to the magnesium ions. In an in vivo study with guinea
pigs’ femurs, it was possible for Witte et al.4 to observe
the additional formation of endosteal and periosteal
bone after 6 and 8 weeks.
Regarding the mechanical properties in this study,
the double extruded implants (type 3, finest grain)
exhibited, as expected, the highest maximum force
(Fmax) in their initial state, which is an advantage for
the stable care of fractures. It is described several times
in the literature that grain refinement is induced by
means of plastic deformation that occurs during extru-
sion18,19 by means of which the mechanical properties
are improved.5,18,19,37 The elongation at rupture, and
therefore the implants’ ductility, was the lowest for
implants possessing the finest grains. This is to be
favourably evaluated for osteosynthesis since the
implant’s deformation would be disadvantageous for
stable care of the fracture. Following the testing, all the
implants exhibited higher elongation values in compari-
son to their initial states. These results, for the type 3
implants, were even statistically significant. Krause et
al.21 also found slightly higher ductility values following
the implantation of WE43 implants after an implanta-
tion period of 6 months compared to those after 3
months. This can be explained using the reduced dia-
meter that is induced by the degradation process and
permits a larger deformation during bending.21 Why
specifically those implants possessing the finest grains
exhibited higher elongations to rupture than in their ini-
tial state cannot be explained with the aid of the current
work and remains the reserve for further investigations.
Conclusion
The in vitro results for the corrosion properties of
alloys possessing various grain sizes and defects are
also reflected in the in vivo results. Implants having
finer grains showed, on average, a slower corrosion rate
and a better clinical tolerance than implants possessing
coarse grains. Defects on the implant’s surface lead to
an initially accelerated corrosion in comparison to
implants without defects. Therefore, attention should
be focussed on a fine-grained alloy with an intact,
smooth surface for applications as a medical product.
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